Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by threefiftynineon Jun 17, 2020 3:50pm

95 Views

Post# 31161827

----JUNE 25TH CLOSING DATE ---

As per the May 26th news on the PP a week tomorrow is the presumed closing date---We should find out whats what after that. Untill then , yes, everything is pure conjecture . Hopefully we get some decent news to cheer everyone up ---but let folks have an opinion--its what boards are for --as repetitive as they may well be---

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China